Per Balschmidt
30Patents
15h-index
42Co-inventors
81Inventor score
Filing activity: Apr 11, 1983 → Aug 18, 2009
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5948751A | X14-mannitol | Human Necessities | 86 | Expired |
| US5164366A | Human insulin analogues | Human Necessities | 65 | Expired |
| US5053389A | Insulin preparation for non-parenteral administration | Human Necessities | 49 | Expired |
| US5157021A | Insulin derivatives and pharmaceutical preparations containing these derivatives | Human Necessities | 42 | Expired |
| US5149777A | Human insulin analogs and preparations containing them | Chemistry; Metallurgy | 40 | Expired |
| US6214547A | Synthetic leader peptide sequences | Chemistry; Metallurgy | 39 | Expired |
| US5898067A | Crystallization of proteins | Chemistry; Metallurgy | 37 | Expired |
| US5705482A | Pharmaceutical formulation | Human Necessities | 34 | Expired |
| US5716927A | Insulin analogs having a modified B-chain | Human Necessities | 33 | Expired |
| US7316999B2 | Glucose dependent release of insulin from glucose sensing insulin derivatives | Chemistry; Metallurgy | 31 | Expired |
| US6500645B1 | N-terminally extended proteins expressed in yeast | Chemistry; Metallurgy | 28 | Expired |
| US6451970B1 | Peptide derivatives | Human Necessities | 22 | Expired |
| US5547930A | Asp.sup.B28 insulin crystals | Human Necessities | 18 | Expired |
| US5834422A | Asp.sup.B28 insulin compositions | Human Necessities | 16 | Expired |
| US5430016A | Insulin compounds and compositions | Human Necessities | 15 | Expired |
| US5028586A | Insulin derivatives and pharmaceutical preparations containing these derivatives | Human Necessities | 14 | Expired |
| US6451762B1 | Aggregates of human insulin derivatives | Human Necessities | 12 | Expired |
| US4601979A | Process for preparing human insulin or B-30 esters thereof | Emerging Cross-Sectional Technologies | 10 | Expired |
| US5840680A | ASP.sup.B28 insulin crystals | Human Necessities | 9 | Expired |
| US9018161B2 | Protease resistant insulin analogues | Human Necessities | 9 | Active |
| US6127334A | Methods for producing biphasic insulin formulations | Human Necessities | 9 | Expired |
| US6022858A | Pharmaceutical formulation of human-growth hormone pretreated with zinc salt | Human Necessities | 7 | Expired |
| US5552385A | Pharmaceutical formulation | Chemistry; Metallurgy | 6 | Expired |
| US9260502B2 | Protease-stabilized insulin analogues | Human Necessities | 6 | Active |
| US7396903B2 | Process for preparing insulin compounds | Chemistry; Metallurgy | 2 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.